drug company accused of trying to block trials aimed at promoting a ` cheap , safe and effective ' treatment for sight loss on the nhs .
it ` bullied ' experts who tried to prove drug can be used to treat blindness .
avastin is effective at tackling wet age-related macular degeneration .
cheaper than the current treatment it would save nhs £ 102million a year .